The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers

Clinical Pharmacology and Therapeutics

Volumn 59, Issue 3, 1996, Pages 297-303

  Chang, Tammy ^a,b   Benet, Leslie Z ^a   Hebert, Mary F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CYCLOSPORIN A; DRUG METABOLITE;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG METABOLISM; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEADY STATE; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; CROSS-OVER STUDIES; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; REFERENCE VALUES; SOLUBILITY; VITAMIN E; WATER;

EID: 0029925318     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)80007-5     Document Type: Article

References (24)

1. Ptachcinski RJ, Venkataramanan R, Burckart GJ. Clinical pharmacokinetics of cyclosporine. Clin Pharmacokinet 1986;11:107-32.
2. Grevel J. Absorption of cyclosporine A after oral dosing. Transplant Proc 1986;18:9-15.
3. Drewe J, Beglinger C, Kissel T. The absorption site of cyclosporin in the human gastrointestinal tract. Br J Clin Pharmacol 1992;33:39-43.
4. Reymond JP, Steimer JL, Niederberger W. On the dose dependency of cyclosporin A absorption and disposition in healthy volunteers. J Pharmacokinet Biopharm 1989;16:331-53.
5. Gupta SK, Manfro RC, Tomlanovich SJ, Gambertoglio JG, Garovoy M, Benet LZ. Effect of food on the pharmacokinetics of cyclosporine in healthy sujects following oral and intravenous administration. J Clin Pharmacol 1990;30:643-53.
6. Sokol RJ, Johnson KE, Karrer FM. Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet 1991;338:212-5.
7. Boudreaux JP, Hayes DH, Mizrahi S, Maggiore P, Blazek J, Dick D. Use of water-soluble liquid vitamin E to enhance cyclosporine absorption in children after liver transplant. Transplant Proc 1993;25:1875.
8. Prueksaritanont T, Koike M, Hoener BA, Benet LZ. Transport and metabolism of cyclosporine in isolated rat hepatocytes: the effect of lipids. Biochem Pharmacol 1992;43:1997-2006.
9. Gomez DY, Wacher VJ, Tomlanovich SJ, Hebert MF, Benet LZ. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine. CLIN PHARMACOL THER 1995;58:15-9.
10. Benet LZ, Galeazzi RL. Noncompartmental determination of the steady-state volume of distribution. J Pharm Sci 1979;68:1071-4.
11. Maurer G, Loosli HR, Keller B. Disposition of cyclosporine in several animal species and man; I: structural elucidation of its metabolites. Drug Metab Dispos 1984;12:120-6.
12. Traber MG, Kayden HJ, Green JB, Green MH. Absorption of water-miscible forms of vitamin E in a patient with cholestasis and in thoracic duct cannulated rats. Am J Clin Nutr 1986;44:914-23.
13. Kovarik JM, Mueller EA, van Bree JB, Tetzloff W, Kutz K. Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J Pharm Sci 1994;83:444-6.
14. Levy G, Brant D. Potential for CsA-Neoral in organ transplantation. Transplant Proc 1994;26:2932-4.
15. Holt DW, Mueller EA, Kovarik JM, van Bree JB, Kutz K. The pharmacokinetics of sandimmun neoral: a new oral formulation of cyclosporine. Transplant Proc 1994;26:2935-9.
16. Vernillet L, Kovarik JM, Freiburghaus R, et al. Blood cyclosporin A and metabolite kinetic profiles after administration of sandimmune soft gelatine capsules and neoral in transplant recipients. Transplant Proc 1994;26:2964-8.
17. Ford JM, Hait WN. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 1990; 42:155-99.
18. Goldberg H, Ling V, Wond PY, Skorecki K. Reduced cyclosporin accumulation in multidrug-resistant cells. Biochem Biophys Res Commun 1988;152:552-8.
19. Twentyman PR. Cyclosporin as drug resistance modifiers. Biochem Pharmacol 1992;43:109-17.
20. Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T. Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem 1993;268:6077-80.
21. Hebert MF, Roberts JP, Prueksaritanont T, Benet LZ. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. CLIN PHARMACOL THER 1992;52:453-7.
22. Wu CY, Hebert MF, Benet LZ. Use of iv and oral drug levels from cyclosporine (CsA) with concomitant rifampin to differentiate gut absorption and metabolism [Abstract]. Pharm Res 1993;10:S345.
23. Wu CY, Benet LZ, Hebert MF, et al. Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine. CLIN PHARMACOL THER 1995;58:492-7.
24. Wacher VJ, Gomez DY, Hebert MF, Tomlanovich SJ, Benet LZ. Differing effects of ketoconazole on the distribution of cyclosporine metabolites after oral and intravenous administration [Abstract]. Pharm Res 1995;12:S372.